Litcius/Paper detail

Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil

Hiromichi Shirasu, Tomoya Yokota, Takeshi Kawakami, Satoshi Hamauchi, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Keita Mori, Tetsuro Onitsuka

2020International Journal of Clinical Oncology21 citationsDOI

Topics & Concepts

MedicineDocetaxelCetuximabCarboplatinNeutropeniaInternal medicineMucositisFebrile neutropeniaInduction chemotherapyHead and neck cancerOncologyHead and neck squamous-cell carcinomaChemotherapyPerformance statusNedaplatinCancerCisplatinColorectal cancerHead and Neck Cancer StudiesEsophageal Cancer Research and TreatmentHead and Neck Surgical Oncology
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil | Litcius